Question | Answer |
Autoimmune disorder. Genetic component. Chronic, progressive, degenerative, inflammatory disease of the CNS. | Multiple Sclerosis |
Group most affected by MS | young women ages 25-35 (although can affect anyone) |
In MS, ___ cells stay and promote infiltration of other agents that damage the immune system and lead to destruction of ________. | T, myelin sheath |
Areas most effected by MS | Optic nerve, cerebrum, brain stem, cerebellum, spinal cord |
80-85% of MS pt will have this type | Type 1: Relapsing remitting |
S/S depend on location and/or the combination of ________ | Lesions (plaques) |
Test in which presence of many lesions (plaques) can be visualized | MRI |
Test shows the presence of IgG molecules bonded together which indicates immune system abnormality. (Via lumbar puncture) | CSF analysis |
Test can help define the extent of the disease process and monitor changes | Evoked Potential Testing |
What lab tests are typically completed since UTI is common | blood and urine |
Test for cognitive issues | Neuropsychological Testing |
What is the cure for MS? | No cure |
Two groups of drugs used primarily during periods of exaserbation. Phenomenal amounts used. Very severe SE | Corticosteroids and Immunosuppressives |
Four drugs for MS and route | Avonex (IM), Betaseron (SQ), Copaxone (SQ), Rebif (SQ) |
Baclofen, Valium, Zanaflex, and Dantrium given for | spasticity |
Symmetrel, Cylert, Prozac given for | Fatigue |
Inderal, Neurontin, Klonopin given for | Ataxia |
NSAIDs, opiates, antidepressants, and antiseizure meds given for | Pain |
Anticholinergics and antispasmodics given for | Bowel and Bladder |